Therapy Areas: Central Nervous System
18 September 2018 - - Veteran biotech executive Arthur Tzianabos, Ph.D. will join the board of directors of US-based Stoke Therapeutics, Inc, the company said.

Dr. Tzianabos, the CEO and ...
18 September 2018 - Supernus Pharmaceuticals Inc (NASDAQ:SUPN) has entered into an agreement to acquire Biscayne Neurotherapeutics, a privately-held company developing a novel treatment for epilepsy, ...
13 September 2018 - - Health Canada has accepted the New Drug Submission for apomorphine sublingual film (APL-130277) to treat motor fluctuations (OFF episodes), experienced by people living with Park...
7 September 2018 - It was reported yesterday that Fulcrum Therapeutics, a company engaged in discovery and development of small molecule therapies for the treatment of serious genetic diseases, has ra...
7 September 2018 - Pharmaceutical company ITF Pharma reported on Thursday the receipt of the US Food and Drug Administration's (FDA) approval for TIGLUTIK (riluzole) oral suspension for the treat...
6 September 2018 - - US-based biopharmaceutical company Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) has entered into an exclusive, worldwide license agreement, through its subsidiary Bio...
Related Headlines